Related Experiment Video
Updated: May 7, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Hypoxia/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH
Jie Gao1, Xuan-sheng Ding, Yu-mao Zhang
1Faculty of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Aim:
Hypoxia/oxidative stress can alter the pharmacokinetics (PK) of CPU86017-RS, a novel antiarrhythmic agent. The aim of this study was to investigate the mechanisms underlying the alteration of PK of CPU86017-RS by hypoxia/oxidative stress.
Methods:
Male SD rats exposed to normal or intermittent hypoxia (10% O2) were administered CPU86017-RS (20, 40 or 80 mg/kg, ig) for 8 consecutive days. The PK parameters of CPU86017-RS were examined on d 8. In a separate set of experiments, female SD rats were injected with isoproterenol (ISO) for 5 consecutive days to induce a stress-related status, then CPU86017-RS (80 mg/kg, ig) was administered, and the tissue distributions were examined. The levels of Mn-SOD (manganese containing superoxide dismutase), endoplasmic reticulum (ER) stress sensor proteins (ATF-6, activating transcription factor 6 and PERK, PRK-like ER kinase) and activation of NADPH oxidase (NOX) were detected with Western blotting. Rat liver microsomes were incubated under N2 for in vitro study.
Results:
The Cmax, t1/2, MRT (mean residence time) and AUC (area under the curve) of CPU86017-RS were significantly increased in the hypoxic rats receiving the 3 different doses of CPU86017-RS. The hypoxia-induced alteration of PK was associated with significantly reduced Mn-SOD level, and increased ATF-6, PERK and NOX levels. In ISO-treated rats, the distributions of CPU86017-RS in plasma, heart, kidney, and liver were markedly increased, and NOX levels in heart, kidney, and liver were significantly upregulated. Co-administration of the NOX blocker apocynin eliminated the abnormalities in the PK and tissue distributions of CPU86017-RS induced by hypoxia/oxidative stress. The metabolism of CPU86017-RS in the N2-treated liver microsomes was significantly reduced, addition of N-acetylcysteine (NAC), but not vitamin C, effectively reversed this change.
Conclusion:
The altered PK and metabolism of CPU86017-RS induced by hypoxia/oxidative stress are produced by mitochondrial abnormalities, NOX activation and ER stress; these abnormalities are significantly alleviated by apocynin or NAC.
Insights
Hypoxia and oxidative stress alter antiarrhythmic CPU86017-RS pharmacokinetics by affecting mitochondrial function and increasing ER stress. Apocynin or N-acetylcysteine (NAC) can reverse these effects.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Biochemistry
Background:
- Hypoxia and oxidative stress can significantly impact drug pharmacokinetics (PK).
- CPU86017-RS is a novel antiarrhythmic agent whose PK may be affected by these conditions.
- Understanding these alterations is crucial for effective therapeutic use.
Purpose of the Study:
- To investigate the mechanisms by which hypoxia/oxidative stress alter the PK of CPU86017-RS.
- To identify potential therapeutic interventions to mitigate these changes.
Main Methods:
- Male and female Sprague-Dawley rats were exposed to hypoxia or isoproterenol (ISO) to induce stress.
- CPU86017-RS was administered, and PK parameters and tissue distribution were analyzed.
- Levels of key proteins involved in oxidative stress (Mn-SOD, NOX) and ER stress (ATF-6, PERK) were measured.
- In vitro studies using liver microsomes assessed drug metabolism.
Main Results:
- Hypoxia significantly increased CPU86017-RS Cmax, t1/2, MRT, and AUC, associated with reduced Mn-SOD and increased ER stress markers and NOX.
- ISO-induced stress increased CPU86017-RS tissue distribution and NOX levels.
- Apocynin (NOX blocker) and N-acetylcysteine (NAC) reversed the PK and distribution abnormalities.
- In vitro metabolism of CPU86017-RS was reduced under hypoxic conditions and restored by NAC.
Conclusions:
- Hypoxia/oxidative stress alter CPU86017-RS PK and metabolism via mitochondrial dysfunction, NOX activation, and ER stress.
- Apocynin and NAC effectively alleviate these stress-induced abnormalities.
- These findings suggest strategies to manage CPU86017-RS therapy in patients experiencing hypoxia or oxidative stress.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Bioactivation and Tissue Toxicity
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Phase I Oxidative Reactions: Overview
Drug Metabolism: Phase I Reactions
Drug Toxicity: Dose-Dependent Reactions

